Filing Details

Accession Number:
0001209191-13-030899
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-05 17:56:44
Reporting Period:
2013-06-03
Filing Date:
2013-06-05
Accepted Time:
2013-06-05 17:56:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1292519 Invivo Therapeutics Holdings Corp. NVIV Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239757 Robert Langer 98 Montvale Road
Newton MA 02459
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-03 2,500 $3.37 7,436,378 No 4 S Direct
Common Stock Disposition 2013-06-04 2,500 $3.90 7,436,128 No 4 S Direct
Common Stock Disposition 2013-06-05 2,500 $3.91 7,433,628 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.40, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.91, inclusive.